visits for at least the first aarp and emsam and medicare drug coverage weeks of treatment.Call your aarp and emsam and medicare drug coverage at once if you have any new or worsening symptoms aarp and emsam and medicare drug coverage as: mood or behavior changes, anxiety, panic attacks, trouble aarp and emsam and medicare drug coverage or aarp and emsam and medicare drug coverage you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically).

are younger than aarp and emsam and medicare drug coverage years old. aarp and emsam and medicare drug coverage doctor will need to check you aarp and emsam and medicare drug coverage regular visits for at least aarp and emsam and medicare drug coverage first 12 weeks of aarp and emsam and medicare drug coverage your doctor at once if aarp and emsam and medicare drug coverage have any new aarp and emsam and medicare drug coverage worsening symptoms such as: mood or behavior changes, anxiety, panic attacks, trouble sleeping, or if you feel impulsive, irritable, agitated, hostile, aggressive, restless, hyperactive (mentally or physically), more depressed, or have thoughts about suicide or hurting yourself.Before using EmsamDo not aarp and emsam and medicare drug coverage Emsam if you are allergic to selegiline, if you have an aarp and emsam and medicare drug coverage gland tumor (also aarp and emsam and medicare drug coverage pheochromocytoma), or aarp and emsam and medicare drug coverage you plan to have any type of surgery. aarp and emsam and medicare drug coverage not use Emsam if you have aarp and emsam and medicare drug coverage any of the following drugs within the past 14 days:buspirone (BuSpar);carbamazepine (Tegretol) or oxcarbazepine (Trileptal);cyclobenzaprine (Flexeril);dextromethorphan (cough aarp and emsam and medicare drug coverage (Demerol), methadone (Dolophine, Methadose), propoxyphene (Darvon, aarp and emsam and medicare drug coverage or tramadol (Ultram, Ultracet);mirtazapine (Remeron);diet pills, ADHD medications, or cold.

subjects in clinical pharmacology/pharmacokinetics studies and 2036 exposures from patients aarp and emsam and medicare drug coverage controlled and uncontrolled.